Phase II trial of capecitabine and rHu-interferon-α-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity

Ena Segota; Tarek Mekhail; Thomas Olencki; Thomas E. Hutson; Robert Dreicer; Brenda Wacker; Bruno Osterwalder; Paul Elson; Ming Zhou; Ronald M. Bukowski

doi:10.1016/j.urolonc.2006.02.016

Phase II trial of capecitabine and rHu-interferon-α-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2006.02.016 ◽

2007 ◽

Vol 25 (1) ◽

pp. 46-52 ◽

Cited By ~ 5

Author(s):

Ena Segota ◽

Tarek Mekhail ◽

Thomas Olencki ◽

Thomas E. Hutson ◽

Robert Dreicer ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

Interferon Α ◽

Limited Efficacy

Download Full-text

Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial

Medical Oncology ◽

10.1007/s12032-011-9982-0 ◽

2011 ◽

Vol 29 (2) ◽

pp. 799-805 ◽

Cited By ~ 21

Author(s):

B. Walter ◽

I. Schrettenbrunner ◽

M. Vogelhuber ◽

J. Grassinger ◽

K. Bross ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

Interferon Α ◽

Prospective Phase

Download Full-text

A randomized phase II trial of interleukin-2/interferon-α plus bevacizumab versus interleukin-2/interferon-α in metastatic renal cell carcinoma (mRCC): Results from the Danish Renal Cancer Group (DARENCA) study 1.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.4563 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 4563-4563 ◽

Cited By ~ 4

Author(s):

Frede Donskov ◽

Niels Viggo Jensen ◽

Torben Smidt-Hansen ◽

Line Brondum ◽

Poul F. Geertsen

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

Interleukin 2 ◽

Interferon Α ◽

Cancer Group ◽

Randomized Phase Ii

Download Full-text

A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1

Acta Oncologica ◽

10.1080/0284186x.2018.1433324 ◽

2018 ◽

Vol 57 (5) ◽

pp. 589-594 ◽

Cited By ~ 5

Author(s):

Frede Donskov ◽

Niels Viggo Jensen ◽

Torben Smidt-Hansen ◽

Line Brøndum ◽

Poul Geertsen

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

Interleukin 2 ◽

Interferon Α ◽

Cancer Group ◽

Randomized Phase Ii

Download Full-text

Interferon-α in combination with either imatinib (Gleevec) or gefitinib (Iressa) in metastatic renal cell carcinoma: a phase II trial

Anti-Cancer Drugs ◽

10.1097/cad.0b013e3282fa4ad2 ◽

2008 ◽

Vol 19 (5) ◽

pp. 527-533 ◽

Cited By ~ 5

Author(s):

Robert J. Amato ◽

Jaroslaw Jac ◽

Joan Hernandez-McClain

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

Interferon Α

Download Full-text

Phase II Trial of Low Dose γ -Interferon in Metastatic Renal Cell Carcinoma

The Journal of Urology ◽

10.1016/s0022-5347(17)32587-9 ◽

1994 ◽

Vol 152 (3) ◽

pp. 841-845 ◽

Cited By ~ 32

Author(s):

Julie A. Ellerhorst ◽

Robert G. Kilbourn ◽

Robert J. Amato ◽

Alexander A. Zukiwski ◽

Elaine Jones ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Low Dose ◽

Phase Ii Trial ◽

Γ Interferon

Download Full-text

An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1262-8 ◽

2010 ◽

Vol 66 (6) ◽

pp. 1065-1070 ◽

Cited By ~ 6

Author(s):

Seiji Naito ◽

Taiji Tsukamoto ◽

Michiyuki Usami ◽

Hiroyuki Fujimoto ◽

Hideyuki Akaza

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Early Phase ◽

Phase Ii Trial ◽

Japanese Patients

Download Full-text

A phase II trial of first-line sorafenib in patients with metastatic renal cell carcinoma unwilling to receive or with early intolerance to immunotherapy: SOGUG Study 06-01

Clinical & Translational Oncology ◽

10.1007/s12094-010-0544-2 ◽

2010 ◽

Vol 12 (7) ◽

pp. 503-508 ◽

Cited By ~ 9

Author(s):

Joaquim Bellmunt ◽

Pablo Maroto-Rey ◽

José M. Trigo ◽

Joan Carles ◽

Vicente Guillem ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

First Line ◽

To Receive

Download Full-text

Immunochemotherapy with interleukin-2, interferon- α and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study

British Journal of Cancer ◽

10.1054/bjoc.1999.0997 ◽

2000 ◽

Vol 82 (4) ◽

pp. 772-776 ◽

Cited By ~ 40

Author(s):

C M L van Herpen ◽

R L H Jansen ◽

W H J Kruit ◽

K Hoekman ◽

G Groenewegen ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Study ◽

Interleukin 2 ◽

Interferon Α ◽

Multicenter Phase

Download Full-text

Granulocyte-Macrophage-Colony Stimulating Factor in Metastatic Renal Cell Carcinoma. A Phase II Trial

The Journal of Urology ◽

10.1016/s0022-5347(01)62035-4 ◽

1999 ◽

Vol 161 (2) ◽

pp. 733-733

Author(s):

B.I. Rini ◽

W.M. Stadler ◽

R.T. Spielberger ◽

M.J. Ratain ◽

N.J. Vogelzang

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

Colony Stimulating Factor ◽

Macrophage Colony Stimulating Factor ◽

Macrophage Colony ◽

Stimulating Factor

Download Full-text

Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma

Urology ◽

10.1016/j.urology.2008.05.032 ◽

2008 ◽

Vol 72 (4) ◽

pp. 898-902 ◽

Cited By ~ 10

Author(s):

Shanthi Marur ◽

James Eliason ◽

Lance K. Heilbrun ◽

Brenda Dickow ◽

Daryn W. Smith ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

Weekly Docetaxel

Download Full-text